Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Factor This
This Week in Cleantech
Factor This Policycast
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Factor This
Factor This Policycast
This Week in Cleantech
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MacroGenics, Inc. - Common Stock
(NQ:
MGNX
)
4.490
-0.170 (-3.65%)
Streaming Delayed Price
Updated: 11:34 AM EDT, Jul 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MacroGenics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
A Look at Macrogenics's Upcoming Earnings Report
↗
May 12, 2025
Via
Benzinga
MacroGenics Announces Date of First Quarter 2025 Financial Results
May 06, 2025
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conference
May 01, 2025
From
MacroGenics, Inc.
Via
GlobeNewswire
Why AZEK Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
March 24, 2025
Via
Benzinga
Peeling Back The Layers: Exploring Macrogenics Through Analyst Insights
↗
November 07, 2024
Via
Benzinga
Macrogenics Earnings Preview
↗
November 04, 2024
Via
Benzinga
MacroGenics (MGNX) Q4 2024 Earnings Call Transcript
↗
March 20, 2025
MGNX earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For March 20, 2025
↗
March 20, 2025
Via
Benzinga
Macrogenics Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
↗
September 18, 2024
Via
Benzinga
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
March 06, 2025
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
February 27, 2025
From
MacroGenics, Inc.
Via
GlobeNewswire
MGNX ALERT: Bragar Eagel & Squire, P.C. is Investigating Macrogenics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
December 10, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conference
December 02, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
November 06, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 06, 2024
Via
Benzinga
MacroGenics (MGNX) Q3 2024 Earnings Call Transcript
↗
November 05, 2024
MGNX earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
MacroGenics Announces Leadership Transition
October 30, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
October 29, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Enters Into Agreement With TerSera Therapeutics for the Sale of MARGENZA®
October 22, 2024
From
TerSera Therapeutics LLC
Via
Business Wire
MGNX Investors Have Opportunity to Join MacroGenics, Inc. Fraud Investigation with the Schall Law Firm
September 24, 2024
From
The Schall Law Firm
Via
Business Wire
MGNX DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages MacroGenics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 24 Deadline in Securities Class Action – MGNX
September 23, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
MGNX Investors Have Opportunity to Lead MacroGenics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
September 23, 2024
From
The Schall Law Firm
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
September 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MacroGenics
September 19, 2024
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MacroGenics and Vicor and Encourages Investors to Contact the Firm
September 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
MGNX Deadline: Rosen Law Firm Urges MacroGenics, Inc. (NASDAQ: MGNX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights
September 17, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
MACROGENICS, INC. (NASDAQ: MGNX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds MacroGenics, Inc. Investors of Upcoming Deadline
September 16, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Investor Reminder (MGNX): Kessler Topaz Meltzer & Check, LLP Reminds MacroGenics, Inc. Investors of September 24, 2024 Deadline
September 16, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
September 15, 2024
From
MacroGenics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
